The way to take Daying 35 (ethinyl estradiol cyproterone tablets) is to take the first tablet from the fifth day of menstruation, twenty-one consecutive days, menstruation within three to seven days after cessation, and the next course of treatment from the fifth day of menstruation.
Ethinyl estradiol cyproterone tablets are contraceptives and are also commonly used clinically in patients with polycystic ovary syndrome. The main ingredient of ethinyl estradiol cyproterone tablets is ethinyl estradiol, and the progestin component is cyproterone, which has the effect of lowering androgen, so it can be used to treat polycystic ovary syndrome.
Ethinylestradiol Cyproterone Tablet has some side effects, which can easily cause gastrointestinal discomfort, such as nausea, vomiting, abdominal pain and other symptoms. It may also cause dizziness, headache, depression and anxiety, as well as weight gain. It impairs liver and kidney function and regular liver and kidney function tests should be done while taking the drug.
The contraindications of ethinyl estradiol cyproterone tablets are unexplained vaginal bleeding, breast hyperplasia or breast cancer, cervical cancer, endometrial cancer, diabetes mellitus, hypertension, thrombotic tendency, uterine fibroids, severe liver disease and other patients are not allowed to use.
Ethinyl estradiol cyproterone tablets may also produce an allergic reaction, if the symptoms are serious need to stop taking in time, under the guidance of the doctor to use anti-allergy drugs.